Disclosure under Regulation 30 of SEBI ( LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals Ltd has made a disclosure under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, via the BSE. The specific nature of the disclosure is not detailed in the available information — Regulation 30 filings can cover a wide range of material events including new orders, contracts, regulatory approvals, or changes in business operations. Investors should refer to the full filing on the BSE website for the exact details of the announcement.
Without knowing the specific subject of the disclosure, it is not possible to assess the impact on shareholders or the stock price. Regulation 30 disclosures are typically made for material events that could influence investor decisions, so the full document should be reviewed before drawing any conclusions.